References
- Akdis M (2006). Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol, 18, 738-44. https://doi.org/10.1016/j.coi.2006.06.003
- Berrino F, De Angelis R, Sant M, et al (2007). Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol, 8, 773-83. https://doi.org/10.1016/S1470-2045(07)70245-0
- Chen X, Li S, Yang Y, et al (2012). Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. J Thromb Haemost, 10, 1508-14. https://doi.org/10.1111/j.1538-7836.2012.04815.x
- Couper KN, Blount DG, Riley EM (2008). IL-10: the master regulator of immunity to infection. J Immunol, 180, 5771-7. https://doi.org/10.4049/jimmunol.180.9.5771
- Eskdale J, Kube D, Tesch H, Gallagher G (1997) Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics, 46, 120-8. https://doi.org/10.1007/s002510050250
- Goswami R, Kaplan MH (2011). A brief history of IL-9. J Immunol, 186, 3283-8. https://doi.org/10.4049/jimmunol.1003049
- Gu H, Ding G, Zhang W, et al (2012). Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep, 39, 9105-11. https://doi.org/10.1007/s11033-012-1782-x
- Howell WM, Rose-Zerilli MJ (2007). Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr, 137, S194-9.
- Imagawa Y, Satake K, Kato Y, Tahara H, Tsukuda M (2004). Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model. Auris Nasus Larynx, 31, 239-45. https://doi.org/10.1016/j.anl.2004.03.008
- Jebreel A, Mistry D, Loke D, et al (2007). Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer. J Laryngol Otol, 121, 246-52.
- Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
- Liu H, Jacobs BS, Liu J, et al (2000). Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: nonneoplastic glia and low-grade astrocytoma differ from malignant glioma. Cancer Immunol Immunother, 49, 319-24. https://doi.org/10.1007/s002620000110
- Macfarlane GJ, Boyle P (1994) The epidemiology of oesophageal cancer in the UK and other European countries. J R Soc Med, 87, 334-7.
- Oh SS, Chang SC, Cai L, et al (2010). Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. Int J Cancer, 127, 2169-82. https://doi.org/10.1002/ijc.25214
- Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Shinomiya T, Mori T, Ariyama Y, et al (1999). Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer, 24, 337-44. https://doi.org/10.1002/(SICI)1098-2264(199904)24:4<337::AID-GCC7>3.0.CO;2-O
- Trinchieri G (2003). Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol, 3, 133-46. https://doi.org/10.1038/nri1001
- Uyttenhove C, Simpson RJ, Van Snick J (1988). Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A, 85, 6934-8. https://doi.org/10.1073/pnas.85.18.6934
- Wu C, Hu Z, He Z, Jia W, et al (2011). Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet, 43, 679-84. https://doi.org/10.1038/ng.849
- Yang XR, Pfeiffer RM, Wheeler W, et al (2009). Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. Int J Cancer, 125, 2912-7. https://doi.org/10.1002/ijc.24622
Cited by
- Interleukin 15 receptor alpha rs2228059 A > C polymorphism decreased risk of gastric cardiac adenocarcinoma in a Chinese population vol.35, pp.7, 2014, https://doi.org/10.1007/s13277-014-1872-6
- Role of +405C>G and +936C>T Polymorphisms of the Vascular Endothelial Growth Factor Gene and Risk of Esophageal Cancer in the Kashmiri Population vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.97
- Association of the interleukin-18 receptor 1 and interleukin-18 receptor accessory protein polymorphisms with the risk of esophageal cancer vol.4, pp.2, 2016, https://doi.org/10.3892/br.2015.552
- Association of IL4 , IL13 , and IL4R polymorphisms with gastrointestinal cancer risk: A meta-analysis vol.27, pp.5, 2017, https://doi.org/10.1016/j.je.2016.06.002
- Functional Variants with Acute Myeloid Leukemia in Turkish Patients vol.20, pp.9, 2016, https://doi.org/10.1089/gtmb.2016.0036